Showing 1,301 - 1,320 results of 1,396 for search '(( significantly delayed decrease ) OR ( significant ((largest decrease) OR (larger decrease)) ))', query time: 0.42s Refine Results
  1. 1301

    Image 2_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.jpeg by Zetong Zheng (22069658)

    Published 2025
    “…Western blot indicated that AQP2 protein levels in LGCs increased as follicles grew larger after luteinization. Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
  2. 1302

    Image 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.tif by Zetong Zheng (22069658)

    Published 2025
    “…Western blot indicated that AQP2 protein levels in LGCs increased as follicles grew larger after luteinization. Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
  3. 1303

    Table 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.docx by Zetong Zheng (22069658)

    Published 2025
    “…Western blot indicated that AQP2 protein levels in LGCs increased as follicles grew larger after luteinization. Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
  4. 1304

    Image 2_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…</p>Results<p>Our studies showed that DC and DRs in VD and AD groups were significantly lower than those in controls, while AC values were significantly higher. …”
  5. 1305

    Image 4_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…</p>Results<p>Our studies showed that DC and DRs in VD and AD groups were significantly lower than those in controls, while AC values were significantly higher. …”
  6. 1306

    Image 3_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…</p>Results<p>Our studies showed that DC and DRs in VD and AD groups were significantly lower than those in controls, while AC values were significantly higher. …”
  7. 1307

    Image 1_Assessment of heart rate deceleration capacity, heart rate deceleration runs, heart rate acceleration capacity, and lipoprotein-related phospholipase A2 as predictors in in... by Yaping Wang (289641)

    Published 2025
    “…</p>Results<p>Our studies showed that DC and DRs in VD and AD groups were significantly lower than those in controls, while AC values were significantly higher. …”
  8. 1308

    Patient characteristics. by Zhiwei Li (131853)

    Published 2025
    “…Furthermore, PCV-VG was associated with an increased center of ventilation (45.1 ± 3.7 vs. 41.7 ± 3.5, P < 0.05), a decrease in global inhomogeneity (GI) (0.85 ± 0.16 vs. 1.06 ± 0.30, P < 0.05), and a reduction in regional ventilation delay index (RVDI) (10.5 ± 4.5 vs. 15.9 ± 5.3, P < 0.05), when compared to VCV. …”
  9. 1309

    CONSORT flow chart of included patients. by Zhiwei Li (131853)

    Published 2025
    “…Furthermore, PCV-VG was associated with an increased center of ventilation (45.1 ± 3.7 vs. 41.7 ± 3.5, P < 0.05), a decrease in global inhomogeneity (GI) (0.85 ± 0.16 vs. 1.06 ± 0.30, P < 0.05), and a reduction in regional ventilation delay index (RVDI) (10.5 ± 4.5 vs. 15.9 ± 5.3, P < 0.05), when compared to VCV. …”
  10. 1310

    Ventilation parameters. by Zhiwei Li (131853)

    Published 2025
    “…Furthermore, PCV-VG was associated with an increased center of ventilation (45.1 ± 3.7 vs. 41.7 ± 3.5, P < 0.05), a decrease in global inhomogeneity (GI) (0.85 ± 0.16 vs. 1.06 ± 0.30, P < 0.05), and a reduction in regional ventilation delay index (RVDI) (10.5 ± 4.5 vs. 15.9 ± 5.3, P < 0.05), when compared to VCV. …”
  11. 1311

    Data Sheet 1_Factors associated with cognitive flexibility in people with opioid-use disorder: a pilot study.docx by Paul S. Regier (8277792)

    Published 2024
    “…Impulsiveness, social function, and depressive symptoms were highly inter-related; however, only higher impulsiveness (r = -.48, p = 0.006) and more social impairment (r = -.47, p = 0.007) significantly correlated with decreased CET (but not n-Back) performance. …”
  12. 1312

    Data Sheet 2_Assessing the impact of moxibustion on colonic mucosal integrity and gut microbiota in a rat model of cerebral ischemic stroke: insights from the “brain-gut axis” theo... by Yi-Xia Ding (20792930)

    Published 2025
    “…</p>Result<p>The model group exhibited significantly higher Longa scores, larger brain infarct size, and higher serum FITC-Dextran levels and ET-1 levels when compared with the sham surgery group (p < 0.01). …”
  13. 1313

    Data Sheet 1_Assessing the impact of moxibustion on colonic mucosal integrity and gut microbiota in a rat model of cerebral ischemic stroke: insights from the “brain-gut axis” theo... by Yi-Xia Ding (20792930)

    Published 2025
    “…</p>Result<p>The model group exhibited significantly higher Longa scores, larger brain infarct size, and higher serum FITC-Dextran levels and ET-1 levels when compared with the sham surgery group (p < 0.01). …”
  14. 1314

    DataSheet1_Treatment and molecular analysis of bullous pemphigoid with tofacitinib: a case report and review of current literature.docx by Xiang Li (114679)

    Published 2024
    “…Immunohistochemical analysis showed tofacitinib significantly decreased the pSTAT3 and pSTAT6 levels in the skin lesions of this patient. …”
  15. 1315

    Table1_Variation of leaf shape with tree size: a case study using Camptotheca acuminata Decne.xlsx by Ke He (331344)

    Published 2024
    “…The centroid ratio slightly decreased with increasing DBH, indicating that larger trees tend to have more ovate leaves than elliptical leaves. …”
  16. 1316

    Data Sheet 1_Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer.docx by Zhijun Chen (254277)

    Published 2025
    “…Tumor volumes in all groups decreased after treatment, with the greatest reduction within 6 months in the combination group (p < 0.001). …”
  17. 1317

    DataSheet2_Treatment and molecular analysis of bullous pemphigoid with tofacitinib: a case report and review of current literature.xlsx by Xiang Li (114679)

    Published 2024
    “…Immunohistochemical analysis showed tofacitinib significantly decreased the pSTAT3 and pSTAT6 levels in the skin lesions of this patient. …”
  18. 1318

    Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial by Trupti Nagendra Prasad (17266455)

    Published 2025
    “…</p><p dir="ltr">Conclusions: Teriparatide demonstrated early improvements in bone microarchitecture in T2D. However, larger, adequately powered studies are needed to establish meaningful comparisons between anabolic and anti-resorptive therapies in this population.…”
  19. 1319

    Data from: Quantifying seed rain patterns in a remnant and a chronosequence of restored tallgrass prairies in north central Missouri by Katherine Wynne (22078346)

    Published 2025
    “…We further found that decreases in seed rain quantity across the chronosequence did not correspond with increases in seed mass, suggesting a lack of tradeoffs between these metrics. …”
  20. 1320

    Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial by Trupti Nagendra Prasad (17266455)

    Published 2025
    “…</p><p dir="ltr">Conclusions: Teriparatide demonstrated early improvements in bone microarchitecture in T2D. However, larger, adequately powered studies are needed to establish meaningful comparisons between anabolic and anti-resorptive therapies in this population.…”